A case‐matched study of toxicity outcomes after proton therapy and intensity‐modulated radiation therapy for prostate cancer

Abstract

In this matched comparison of prospectively collected toxicity data on patients with PCa who received treatment with contemporary IMRT and PBT techniques and similar dose-fractionation schedules, the risks of acute and late GI/GU toxicities did not differ significantly after adjustment for confounders and predictive factors.